查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1446524

肿瘤学中的人工智慧市场规模、份额、趋势分析报告：按组件类型、按癌症类型、按应用、按最终用途、按地区、细分市场预测，2024-2030 年

AI In Oncology Market Size, Share & Trends Analysis Report By Component Type (Software Solutions, Hardware), By Cancer Type (Breast Cancer, Lung Cancer), By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

肿瘤学领域的人工智慧市场成长与趋势：

Grand View Research, Inc.最新报告显示，到2030年，全球肿瘤领域人工智慧市场规模预计将达到191.7亿美元，2024年至2030年复合年增长率为28.92%。

由于全球人口中癌症盛行率不断上升，以及开发技术先进的产品来诊断、治疗和分析癌症的需求不断增长，预计该市场将大幅增长。例如，国际癌症研究机构（IARC）预测，2023年新患者将超过2,070万例。此外，人工智慧对于实现早期检测和降低死亡率至关重要，特别是透过有效的筛检计画。

由于生活方式的改变和人口老化等多种因素，新兴市场的癌症盛行率正在增加。这些市场中癌症患者的迅速增加正在产生对肿瘤学人工智慧等先进技术的需求，以改善早期检测、个人化治疗和整体患者治疗结果。例如，2024年1月，印度首个人工智慧精准肿瘤中心（POC）在班加罗尔阿波罗癌症中心开幕。该 POC 利用人工智慧提供的巨大可能性，帮助肿瘤学家、患者和看护者在指定时间内实现最佳结果。

人工智慧透过将多组体学分析的大量资料集与深度学习和高效能运算技术的最新发展相结合，正在改变肿瘤学领域。人工智慧的应用正在扩展到新的检测、筛检、诊断和分类方法、癌症基因组学表征、肿瘤微环境分析、预后和预测生物标记评估、后续观察和药物发现策略。例如，2022 年 10 月，Model Medicines 启动了一项肿瘤学计划，重点是识别和开发针对两个磊晶和致癌性标靶的疗法，重点是在固态和骨髓恶性肿瘤中的应用。

市场上的主要企业正在建立合作伙伴关係和联合研究，重点关注新产品开发，以协助早期癌症诊断，满足不断增长的需求，并加强开发平臺。策略已被采用。例如，2022年12月，Astra Zeneca与Clinicink合作推出肺癌AI计划。该计划旨在及早发现肺癌并支持有效治疗方法的开发。

此外，2022 年 11 月，Google Health 与 iCAD 建立合作伙伴关係，致力于利用该公司的人工智慧技术改善乳癌筛检。此外，许多公共和私人组织都专注于资助和投资基于人工智慧的肿瘤筛检产品的研发。例如，2023 年 3 月，Artera 获得了 9,000 万美元的资金，用于推出和行销 ArteraAI 前列腺测试，这是第一个为预测局部前列腺癌治疗而开发的测试。

肿瘤学市场人工智慧报告亮点

  • 按组件类型划分，软体解决方案领域预计在预测期内将以最快的复合年增长率成长。
  • 以癌症类型来看，摄护腺癌在人群中的盛行率正在不断上升，预计在预测期内将以最快的复合年增长率成长。根据 CDC 发布的资料，在美国，每 100 名男性中就有 13 人患有前列腺癌。
  • 从应用来看，研发产业预计在预测期内将以有利的复合年增长率成长。这是由于製药公司广泛采用和融合先进的人工智慧演算法。
  • 从最终用途来看，医院占据市场主导地位，成长最快。这是因为越来越多的公司正在医院共同开发或实施人工智慧驱动的癌症治疗解决方案。
  • 由于政府的积极倡议和数位基础设施的可用性为患者提供数位解决方案，北美主导了市场。

目录

第一章调查方法和范围

第 2 章执行摘要

第 3 章：肿瘤学领域的人工智慧市场变数、趋势和范围

  • 市场体系展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 营商环境分析
    • 产业分析-波特五力分析
    • PESTEL分析
  • COVID-19 对肿瘤市场人工智慧的影响

第 4 章：肿瘤学中的人工智慧市场細項分析（按组成部分）

  • 定义和范围
  • 组件细分仪表板
  • 2018-2030 年全球肿瘤市场人工智慧组件
  • 软体解决方案
    • 软体解决方案市场，2018-2030
  • 硬体
    • 硬体市场，2018-2030
  • 服务
    • 服务市场，2018-2030

第 5 章：肿瘤学中的人工智慧市场細項分析（按癌症类型）

  • 定义和范围
  • 癌症类型细分仪表板
  • 2018年至2030年市场规模、预测与趋势分析
  • 乳癌
    • 2018-2030 年乳癌市场估计与预测
  • 肺癌
    • 2018-2030 年肺癌市场估计与预测
  • 摄护腺癌
    • 2018-2030 年前列腺癌市场估计与预测
  • 大肠直肠癌
    • 2018年至2030年大肠癌市场估计与预测
  • 脑肿瘤
    • 2018年至2030年脑瘤市场估计与预测
  • 其他的
    • 2018-2030 年其他市场估计与预测

第 6 章：肿瘤学中的人工智慧市场細項分析（按应用）

  • 定义和范围
  • 使用细分仪表板
  • 2018年至2030年市场规模、预测与趋势分析
  • 诊断（病理学、癌症放射学）
    • 诊断
  • 放射线治疗（放射线治疗）
    • 放射治疗
  • 研究与开发（药物发现、开发过程等）
    • 研究与开发
  • 化疗
    • 2018-2030 年化疗市场估计与预测
  • 免疫疗法
    • 2018-2030 年免疫治疗市场估计与预测

第 7 章：肿瘤学中的人工智慧市场細項分析（按最终用途类型）

  • 定义和范围
  • 最终用途细分仪表板
  • 2018年至2030年市场规模、预测与趋势分析
  • 医院
    • 医院市场，2018-2030
  • 外科中心和医疗机构
    • 2018-2030 年手术中心和医疗机构市场估计和预测
  • 其他（製药公司、研究机构、训练中心）
    • 其他的

第 8 章：肿瘤学中的人工智慧市场細項分析（按地区、组成部分、癌症类型、应用和最终用途）

  • 定义和范围
  • 2023 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 区域市场简介
  • SWOT分析
  • 北美洲
    • 北美肿瘤人工智慧市场，2018-2030
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲肿瘤学人工智慧市场，2018-2030
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 亚太地区肿瘤市场人工智慧，2018-2030
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 拉丁美洲肿瘤市场人工智慧，2018-2030
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • 中东和非洲肿瘤学人工智慧市场，2018-2030
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第九章肿瘤学人工智慧市场—竞争分析

  • 主要市场参与企业的最新趋势和影响分析
  • 公司分类
  • 公司简介
    • Azra AI
    • IBM
    • Siemens Healthcare GmbH
    • Intel Corporation
    • GE HealthCare
    • NVIDIA Corporation
    • Digital Diagnostics Inc.
    • ConcertAI
    • Median Technologies
    • PathAI
Product Code: GVR-4-68039-985-7

AI In Oncology Market Growth & Trends:

The global AI in oncology market size is expected to reach USD 19.17 billion by 2030, registering a CAGR of 28.92% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is anticipated to witness significant growth owing to increasing prevalence of cancer among the global population, propelling the need to develop technologically advanced products to diagnose, treat, and analyze cancer. For instance, the International Agency for Research on Cancer (IARC) expects over 20.7 million new cases in 2023. Moreover, AI enables early detection, crucial for lowering mortality, especially through efficient screening programs.

Emerging markets are witnessing a rising prevalence of cancer due to various factors, including lifestyle changes & aging populations. The surge in cancer cases in these markets creates a demand for advanced technologies like AI in oncology to improve early detection, personalized treatment, and overall patient outcomes. For instance, in January 2024, India's first AI-Precision Oncology Centre (POC) was launched at Apollo Cancer Centre in Bengaluru. The POC will utilize the vast possibilities offered by AI to help oncologists, patients, and caregivers achieve the best possible results within a specified time frame.

AI is transforming the field of oncology by integrating vast datasets from multi-omics analyses with the latest developments in deep learning and high-performance computing techniques. AI applications are expanding to include new detection, screening, diagnosis, and classification approaches, cancer genomics characterization, tumor microenvironment analysis, prognostic and predictive biomarkers assessment, and strategies for follow-up and drug discovery. For instance, in October 2022, Model Medicines launched an oncology program focusing on identifying and developing therapeutics against two epigenetic and oncogenic targets, focusing on applications for solid and hematological malignancies.

The major players operating in the market are adopting strategies such as collaborations and partnerships with a major focus on development of newer products to aid in the early diagnosis of cancer, meet rising demand, and enhance research and development pipeline. For instance, in December 2022, AstraZeneca collaborated with Clinithink to launch an AI project for lung cancer. This project aims to detect lung cancer at an early stage to aid in the developing of effective treatment.

Furthermore, in November 2022, Google Health entered into a partnership with iCAD, Inc. for the improvement of breast cancer screening using the company's artificial intelligence technology. Additionally, a number of public and private organizations are focusing on funding and investment for R&D in AI-based oncology screening products. For instance, in March 2023, Artera received funding of USD 90 million for the launch and distribution of the ArteraAI Prostate Test, the first developed test for predicting therapy in localized prostate cancer.

AI In Oncology Market Report Highlights:

  • Based on component type, the software solutions segment is anticipated to grow at the fastest CAGR over the forecast period, owing to increasing adoption of software solutions for a wide number of applications due to the better outcomes offered by this component
  • Based on cancer type, the prostate cancer segment is anticipated to grow at the fastest CAGR over the forecast period in the market with rising prevalence amongst the population. Prostate cancer generally affects 13 out of every 100 men in the U.S., according to the data published by CDC
  • Based on application type, the research and development segment is expected to grow at the lucrative CAGR over the forecast period. This is attributable to the widespread adoption and amalgamation of advanced AI-enabled algorithms in pharmaceutical companies
  • Based on end-use, the hospitals dominated the market and registered the fastest growth owing to growing number of companies collaborating or introducing AI-powered cancer care solutions in hospitals
  • North America dominated the market due to the availability of favorable government initiatives and digital infrastructure to provide digital solutions to patients

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
    • 2.2.1. Component outlook
    • 2.2.2. Cancer type outlook
    • 2.2.3. Application outlook
    • 2.2.4. End-use outlook
  • 2.3. Competitive Landscape Snapshot

Chapter 3. AI In Oncology Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing demand for early detection and classification of cancer
      • 3.2.1.1.1.Case study 1
      • 3.2.1.1.2.Case study 2
      • 3.2.1.2. Increasing prevalence of cancer
      • 3.2.1.2.1.Breast
      • 3.2.1.2.2.Barain & CNS
      • 3.2.1.2.3.Kidney
      • 3.2.1.2.4.Non-Hodgkin lymphoma
      • 3.2.1.2.5.Bladder
      • 3.2.1.2.6.Colon & rectum
      • 3.2.1.2.7.Prostate
      • 3.2.1.2.8.Case Study 3
      • 3.2.1.3. Rising adoption of precision medicine
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High procurement and implementation cost
      • 3.2.2.2. Lack of skilled workforce
      • 3.2.2.3. High impact of regulations
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
  • 3.4. Impact of COVID-19 on AI in Oncology Market

Chapter 4. AI In Oncology Market Segment Analysis, By Component, 2018 - 2030 (USD Million)

  • 4.1. Definition and Scope
  • 4.2. Component Segment Dashboard
  • 4.3. Global AI In Oncology Market, by Component, 2018 to 2030
  • 4.4. Software Solution
    • 4.4.1. Software Solution Market, 2018 - 2030 (USD Million)
  • 4.5. Hardware
    • 4.5.1. Hardware Market, 2018 - 2030 (USD Million)
  • 4.6. Services
    • 4.6.1. Services Market, 2018 - 2030 (USD Million)

Chapter 5. AI In Oncology Market Segment Analysis, By Cancer Type, 2018 - 2030 (USD Million)

  • 5.1. Definition and Scope
  • 5.2. Cancer Type Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.4. Breast Cancer
    • 5.4.1. Breast cancer market estimates and forecast, 2018 - 2030 (USD Million)
  • 5.5. Lung Cancer
    • 5.5.1. Lung cancer market estimates and forecast, 2018 - 2030 (USD Million)
  • 5.6. Prostate Cancer
    • 5.6.1. Prostate cancer market estimates and forecast, 2018 - 2030 (USD Million)
  • 5.7. Colorectal Cancer
    • 5.7.1. Colorectal cancer market estimates and forecast, 2018 - 2030 (USD Million)
  • 5.8. Brain Tumor
    • 5.8.1. Brain tumor market estimates and forecast, 2018 - 2030 (USD Million)
  • 5.9. Others
    • 5.9.1. Others market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 6. AI In Oncology Market Segment Analysis, By Application, 2018 - 2030 (USD Million)

  • 6.1. Definition and Scope
  • 6.2. Application Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.4. Diagnostics (Pathology, Cancer Radiology)
    • 6.4.1. Diagnostics (pathology, cancer radiology) market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.5. Radiation Therapy (Radiotherapy)
    • 6.5.1. Radiation therapy (radiotherapy) market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.6. Research & Development (Drug Design, Development Process, etc.)
    • 6.6.1. Research & development (drug design, development process, etc.) market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.7. Chemotherapy
    • 6.7.1. Chemotherapy market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.8. Immunotherapy
    • 6.8.1. Immunotherapy market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 7. AI In Oncology Market Segment Analysis, By End-use Type, 2018 - 2030 (USD Million)

  • 7.1. Definitions and Scope
  • 7.2. End-use Segment Dashboard
  • 7.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 7.4. Hospitals
    • 7.4.1. Hospitals Market, 2018 - 2030 (USD Million)
  • 7.5. Surgical Centers & Medical Institutes
    • 7.5.1. Surgical centers & medical institutes market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.6. Others (Pharmaceutical Companies, Research Institutes & Training Centers)
    • 7.6.1. Others (pharmaceutical companies, research institutes & training centers) market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 8. AI In Oncology Market Segment Analysis, By Region, By Component, By Cancer Type, By Application, By End-use, 2018 - 2030 (USD Million)

  • 8.1. Definition & Scope
  • 8.2. Regional Market Share Analysis, 2023 & 2030
  • 8.3. Regional Market Dashboard
  • 8.4. Regional Market Snapshot
  • 8.5. SWOT Analysis
  • 8.6. North America
    • 8.6.1. North America Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
    • 8.6.2. U.S.
      • 8.6.2.1. Key Country Dynamic
      • 8.6.2.2. Regulatory Framework
      • 8.6.2.3. Competitive Insights
      • 8.6.2.4. U.S. Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
    • 8.6.3. Canada
      • 8.6.3.1. Key Country Dynamic
      • 8.6.3.2. Regulatory Framework
      • 8.6.3.3. Competitive Insights
      • 8.6.3.4. Canada Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
  • 8.7. Europe
    • 8.7.1. Europe Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
    • 8.7.2. Germany
      • 8.7.2.1. Key Country Dynamic
      • 8.7.2.2. Regulatory Framework
      • 8.7.2.3. Competitive Insights
      • 8.7.2.4. Germany Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
    • 8.7.3. UK
      • 8.7.3.1. Key Country Dynamic
      • 8.7.3.2. Regulatory Framework
      • 8.7.3.3. Competitive Insights
      • 8.7.3.4. UK Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
    • 8.7.4. France
      • 8.7.4.1. Key Country Dynamic
      • 8.7.4.2. Regulatory Framework
      • 8.7.4.3. Competitive Insights
      • 8.7.4.4. France Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
    • 8.7.5. Italy
      • 8.7.5.1. Key Country Dynamic
      • 8.7.5.2. Regulatory Framework
      • 8.7.5.3. Competitive Insights
      • 8.7.5.4. Italy Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
    • 8.7.6. Spain
      • 8.7.6.1. Key Country Dynamic
      • 8.7.6.2. Regulatory Framework
      • 8.7.6.3. Competitive Insights
      • 8.7.6.4. Spain Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
    • 8.7.7. Denmark
      • 8.7.7.1. Key Country Dynamic
      • 8.7.7.2. Regulatory Framework
      • 8.7.7.3. Competitive Insights
      • 8.7.7.4. Denmark Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
    • 8.7.8. Sweden
      • 8.7.8.1. Key Country Dynamic
      • 8.7.8.2. Regulatory Framework
      • 8.7.8.3. Competitive Insights
      • 8.7.8.4. Sweden Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
    • 8.7.9. Norway
      • 8.7.9.1. Key Country Dynamic
      • 8.7.9.2. Regulatory Framework
      • 8.7.9.3. Competitive Insights
      • 8.7.9.4. Norway Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
  • 8.8. Asia Pacific
    • 8.8.1. Asia Pacific Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
    • 8.8.2. Japan
      • 8.8.2.1. Key Country Dynamic
      • 8.8.2.2. Regulatory Framework
      • 8.8.2.3. Competitive Insights
      • 8.8.2.4. Japan Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
    • 8.8.3. China
      • 8.8.3.1. Key Country Dynamic
      • 8.8.3.2. Regulatory Framework
      • 8.8.3.3. Competitive Insights
      • 8.8.3.4. China Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
    • 8.8.4. India
      • 8.8.4.1. Key Country Dynamic
      • 8.8.4.2. Regulatory Framework
      • 8.8.4.3. Competitive Insights
      • 8.8.4.4. India Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
    • 8.8.5. South Korea
      • 8.8.5.1. Key Country Dynamic
      • 8.8.5.2. Regulatory Framework
      • 8.8.5.3. Competitive Insights
      • 8.8.5.4. South Korea Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
    • 8.8.6. Australia
      • 8.8.6.1. Key Country Dynamic
      • 8.8.6.2. Regulatory Framework
      • 8.8.6.3. Competitive Insights
      • 8.8.6.4. Australia Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
    • 8.8.7. Thailand
      • 8.8.7.1. Key Country Dynamic
      • 8.8.7.2. Regulatory Framework
      • 8.8.7.3. Competitive Insights
      • 8.8.7.4. Thailand Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
  • 8.9. Latin America
    • 8.9.1. Latin America Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
    • 8.9.2. Brazil
      • 8.9.2.1. Key Country Dynamic
      • 8.9.2.2. Regulatory Framework
      • 8.9.2.3. Competitive Insights
      • 8.9.2.4. Brazil Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
    • 8.9.3. Mexico
      • 8.9.3.1. Key Country Dynamic
      • 8.9.3.2. Regulatory Framework
      • 8.9.3.3. Competitive Insights
      • 8.9.3.4. Mexico Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
    • 8.9.4. Argentina
      • 8.9.4.1. Key Country Dynamic
      • 8.9.4.2. Regulatory Framework
      • 8.9.4.3. Competitive Insights
      • 8.9.4.4. Argentina Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
  • 8.10. MEA
    • 8.10.1. MEA Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
    • 8.10.2. South Africa
      • 8.10.2.1. Key Country Dynamic
      • 8.10.2.2. Regulatory Framework
      • 8.10.2.3. Competitive Insights
      • 8.10.2.4. South Africa Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
    • 8.10.3. Saudi Arabia
      • 8.10.3.1. Key Country Dynamic
      • 8.10.3.2. Regulatory Framework
      • 8.10.3.3. Competitive Insights
      • 8.10.3.4. Saudi Arabia Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
    • 8.10.4. UAE
      • 8.10.4.1. Key Country Dynamic
      • 8.10.4.2. Regulatory Framework
      • 8.10.4.3. Competitive Insights
      • 8.10.4.4. UAE Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
    • 8.10.5. Kuwait
      • 8.10.5.1. Key Country Dynamic
      • 8.10.5.2. Regulatory Framework
      • 8.10.5.3. Competitive Insights
      • 8.10.5.4. Kuwait Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)

Chapter 9. AI In Oncology Market - Competitive Analysis

  • 9.1. Recent Developments & Impact Analysis, by Key Market Participants
  • 9.2. Company Categorization
  • 9.3. Company Profiles
    • 9.3.1. Azra AI
      • 9.3.1.1. Overview
      • 9.3.1.2. Financial Performance
      • 9.3.1.3. Service Benchmarking
      • 9.3.1.4. Strategic Initiatives
    • 9.3.2. IBM
      • 9.3.2.1. Overview
      • 9.3.2.2. Financial Performance
      • 9.3.2.3. Service Benchmarking
      • 9.3.2.4. Strategic Initiatives
    • 9.3.3. Siemens Healthcare GmbH
      • 9.3.3.1. Overview
      • 9.3.3.2. Financial Performance
      • 9.3.3.3. Service Benchmarking
      • 9.3.3.4. Strategic Initiatives
    • 9.3.4. Intel Corporation
      • 9.3.4.1. Overview
      • 9.3.4.2. Financial Performance
      • 9.3.4.3. Service Benchmarking
      • 9.3.4.4. Strategic Initiatives
    • 9.3.5. GE HealthCare
      • 9.3.5.1. Overview
      • 9.3.5.2. Financial Performance
      • 9.3.5.3. Service Benchmarking
      • 9.3.5.4. Strategic Initiatives
    • 9.3.6. NVIDIA Corporation
      • 9.3.6.1. Overview
      • 9.3.6.2. Financial Performance
      • 9.3.6.3. Service Benchmarking
      • 9.3.6.4. Strategic Initiatives
    • 9.3.7. Digital Diagnostics Inc.
      • 9.3.7.1. Overview
      • 9.3.7.2. Financial Performance
      • 9.3.7.3. Service Benchmarking
      • 9.3.7.4. Strategic Initiatives
    • 9.3.8. ConcertAI
      • 9.3.8.1. Overview
      • 9.3.8.2. Financial Performance
      • 9.3.8.3. Service Benchmarking
      • 9.3.8.4. Strategic Initiatives
    • 9.3.9. Median Technologies
      • 9.3.9.1. Overview
      • 9.3.9.2. Financial Performance
      • 9.3.9.3. Service Benchmarking
      • 9.3.9.4. Strategic Initiatives
    • 9.3.10. PathAI
      • 9.3.10.1. Overview
      • 9.3.10.2. Financial Performance
      • 9.3.10.3. Service Benchmarking
      • 9.3.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global AI in oncology market, by region, 2018 - 2030 (USD Million)
  • Table 4 Global AI in oncology market, by component, 2018 - 2030 (USD Million)
  • Table 5 Global AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
  • Table 6 Global AI in oncology market, by application, 2018 - 2030 (USD Million)
  • Table 7 Global AI in oncology market, by end-use, 2018 - 2030 (USD Million)
  • Table 8 North America AI in oncology market, by region, 2018 - 2030 (USD Million)
  • Table 9 North America AI in oncology market, by component, 2018 - 2030 (USD Million)
  • Table 10 North America AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
  • Table 11 North America AI in oncology market, by application, 2018 - 2030 (USD Million)
  • Table 12 North America AI in oncology market, by end-use, 2018 - 2030 (USD Million)
  • Table 13 U.S. AI in oncology market, by component, 2018 - 2030 (USD Million)
  • Table 14 U.S. AI in oncology market, by application, 2018 - 2030 (USD Million)
  • Table 15 U.S. AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
  • Table 16 U.S. AI in oncology market, by end-use, 2018 - 2030 (USD Million)
  • Table 17 Canada AI in oncology market, by component, 2018 - 2030 (USD Million)
  • Table 18 Canada AI in oncology market, by application, 2018 - 2030 (USD Million)
  • Table 19 Canada AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
  • Table 20 Canada AI in oncology market, by end-use, 2018 - 2030 (USD Million)
  • Table 21 Europe AI in oncology market, by region, 2018 - 2030 (USD Million)
  • Table 22 Europe AI in oncology market, by component, 2018 - 2030 (USD Million)
  • Table 23 Europe AI in oncology market, by application, 2018 - 2030 (USD Million)
  • Table 24 Europe AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
  • Table 25 Europe AI in oncology market, by end-use, 2018 - 2030 (USD Million)
  • Table 26 Germany AI in oncology market, by component, 2018 - 2030 (USD Million)
  • Table 27 Germany AI in oncology market, by application, 2018 - 2030 (USD Million)
  • Table 28 Germany AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
  • Table 29 Germany AI in oncology market, by end-use, 2018 - 2030 (USD Million)
  • Table 30 UK AI in oncology market, by component, 2018 - 2030 (USD Million)
  • Table 31 UK AI in oncology market, by application, 2018 - 2030 (USD Million)
  • Table 32 UK AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
  • Table 33 UK AI in oncology market, by end-use, 2018 - 2030 (USD Million)
  • Table 34 France AI in oncology market, by component, 2018 - 2030 (USD Million)
  • Table 35 France AI in oncology market, by application, 2018 - 2030 (USD Million)
  • Table 36 France AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
  • Table 37 France AI in oncology market, by end-use, 2018 - 2030 (USD Million)
  • Table 38 Italy AI in oncology market, by component, 2018 - 2030 (USD Million)
  • Table 39 Italy AI in oncology market, by application, 2018 - 2030 (USD Million)
  • Table 40 Italy AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
  • Table 41 Italy AI in oncology market, by end-use, 2018 - 2030 (USD Million)
  • Table 42 Spain AI in oncology market, by component, 2018 - 2030 (USD Million)
  • Table 43 Spain AI in oncology market, by application, 2018 - 2030 (USD Million)
  • Table 44 Spain AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
  • Table 45 Spain AI in oncology market, by end-use, 2018 - 2030 (USD Million)
  • Table 46 Denmark AI in oncology market, by component, 2018 - 2030 (USD Million)
  • Table 47 Denmark AI in oncology market, by application, 2018 - 2030 (USD Million)
  • Table 48 Denmark AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
  • Table 49 Denmark AI in oncology market, by end-use, 2018 - 2030 (USD Million)
  • Table 50 Sweden AI in oncology market, by component, 2018 - 2030 (USD Million)
  • Table 51 Sweden AI in oncology market, by application, 2018 - 2030 (USD Million)
  • Table 52 Sweden AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
  • Table 53 Sweden AI in oncology market, by end-use, 2018 - 2030 (USD Million)
  • Table 54 Norway AI in oncology market, by component, 2018 - 2030 (USD Million)
  • Table 55 Norway AI in oncology market, by application, 2018 - 2030 (USD Million)
  • Table 56 Norway AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
  • Table 57 Norway AI in oncology market, by end-use, 2018 - 2030 (USD Million)
  • Table 58 Asia Pacific AI in oncology market, by region, 2018 - 2030 (USD Million)
  • Table 59 Asia Pacific AI in oncology market, by component, 2018 - 2030 (USD Million)
  • Table 60 Asia Pacific AI in oncology market, by application, 2018 - 2030 (USD Million)
  • Table 61 Asia Pacific AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
  • Table 62 Asia Pacific AI in oncology market, by end-use, 2018 - 2030 (USD Million)
  • Table 63 China AI in oncology market, by component, 2018 - 2030 (USD Million)
  • Table 64 China AI in oncology market, by application, 2018 - 2030 (USD Million)
  • Table 65 China AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
  • Table 66 China AI in oncology market, by end-use, 2018 - 2030 (USD Million)
  • Table 67 Japan AI in oncology market, by component, 2018 - 2030 (USD Million)
  • Table 68 Japan AI in oncology market, by application, 2018 - 2030 (USD Million)
  • Table 69 Japan AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
  • Table 70 Japan AI in oncology market, by end-use, 2018 - 2030 (USD Million)
  • Table 71 India AI in oncology market, by component, 2018 - 2030 (USD Million)
  • Table 72 India AI in oncology market, by application, 2018 - 2030 (USD Million)
  • Table 73 India AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
  • Table 74 India AI in oncology market, by end-use, 2018 - 2030 (USD Million)
  • Table 75 South Korea AI in oncology market, by component, 2018 - 2030 (USD Million)
  • Table 76 South Korea AI in oncology market, by application, 2018 - 2030 (USD Million)
  • Table 77 South Korea AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
  • Table 78 South Korea AI in oncology market, by end-use, 2018 - 2030 (USD Million)
  • Table 79 Australia AI in oncology market, by component, 2018 - 2030 (USD Million)
  • Table 80 Australia AI in oncology market, by application, 2018 - 2030 (USD Million)
  • Table 81 Australia AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
  • Table 82 Australia AI in oncology market, by end-use, 2018 - 2030 (USD Million)
  • Table 83 Thailand AI in oncology market, by component, 2018 - 2030 (USD Million)
  • Table 84 Thailand AI in oncology market, by application, 2018 - 2030 (USD Million)
  • Table 85 Thailand AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
  • Table 86 Thailand AI in oncology market, by end-use, 2018 - 2030 (USD Million)
  • Table 87 Latin America AI in oncology market, by region, 2018 - 2030 (USD Million)
  • Table 88 Latin America AI in oncology market, by component, 2018 - 2030 (USD Million)
  • Table 89 Latin America AI in oncology market, by application, 2018 - 2030 (USD Million)
  • Table 90 Latin America AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
  • Table 91 Latin America AI in oncology market, by end-use, 2018 - 2030 (USD Million)
  • Table 92 Brazil AI in oncology market, by component, 2018 - 2030 (USD Million)
  • Table 93 Brazil AI in oncology market, by application, 2018 - 2030 (USD Million)
  • Table 94 Brazil AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
  • Table 95 Brazil AI in oncology market, by end-use, 2018 - 2030 (USD Million)
  • Table 96 Mexico AI in oncology market, by component, 2018 - 2030 (USD Million)
  • Table 97 Mexico AI in oncology market, by application, 2018 - 2030 (USD Million)
  • Table 98 Mexico AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
  • Table 99 Mexico AI in oncology market, by end-use, 2018 - 2030 (USD Million)
  • Table 100 Argentina AI in oncology market, by component, 2018 - 2030 (USD Million)
  • Table 101 Argentina AI in oncology market, by application, 2018 - 2030 (USD Million)
  • Table 102 Argentina AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
  • Table 103 Argentina AI in oncology market, by end-use, 2018 - 2030 (USD Million)
  • Table 104 MEA AI in oncology market, by region, 2018 - 2030 (USD Million)
  • Table 105 MEA AI in oncology market, by component, 2018 - 2030 (USD Million)
  • Table 106 MEA AI in oncology market, by application, 2018 - 2030 (USD Million)
  • Table 107 MEA AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
  • Table 108 MEA AI in oncology market, by end-use, 2018 - 2030 (USD Million)
  • Table 109 South Africa AI in oncology market, by component, 2018 - 2030 (USD Million)
  • Table 110 South Africa AI in oncology market, by application, 2018 - 2030 (USD Million)
  • Table 111 South Africa AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
  • Table 112 South Africa AI in oncology market, by end-use, 2018 - 2030 (USD Million)
  • Table 113 Saudi Arabia AI in oncology market, by component, 2018 - 2030 (USD Million)
  • Table 114 Saudi Arabia AI in oncology market, by application, 2018 - 2030 (USD Million)
  • Table 115 Saudi Arabia AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
  • Table 116 Saudi Arabia AI in oncology market, by end-use, 2018 - 2030 (USD Million)
  • Table 117 UAE AI in oncology market, by component, 2018 - 2030 (USD Million)
  • Table 118 UAE AI in oncology market, by application, 2018 - 2030 (USD Million)
  • Table 119 UAE AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
  • Table 120 UAE AI in oncology market, by end-use, 2018 - 2030 (USD Million)
  • Table 121 Kuwait AI in oncology market, by component, 2018 - 2030 (USD Million)
  • Table 122 Kuwait AI in oncology market, by application, 2018 - 2030 (USD Million)
  • Table 123 Kuwait AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
  • Table 124 Kuwait AI in oncology market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 AI in Oncology Market Segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Commodity flow analysis
  • Fig. 5 Parent market analysis
  • Fig. 6 AI in oncology Market snapshot
  • Fig. 7 AI in oncology Market segment snapshot
  • Fig. 8 AI in oncology Market segment snapshot
  • Fig. 9 AI in oncology Market competitive landscape snapshot
  • Fig. 10 Market research process
  • Fig. 11 Parent market outlook (USD Billion) (2023)
  • Fig. 12 AI in oncology market dynamics
  • Fig. 13 Areas of interest most likely to benefit from AI in the next 10 years
  • Fig. 14 Anticipated Clinical Impact: Key Areas where AI is Poised to Make a Significant Difference
  • Fig. 15 Comparison between AI-integrated healthcare and traditional healthcare
  • Fig. 16 Porter's Analysis
  • Fig. 17 PESTEL Analysis
  • Fig. 18 AI in oncology market, component outlook key takeaways (USD Million)
  • Fig. 19 AI in oncology market: Component movement analysis, 2023 & 2030 (USD Million)
  • Fig. 20 Software solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Hardware market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 AI in cancer diagnostics market, cancer type outlook key takeaways (USD Million)
  • Fig. 24 AI in oncology market: Cancer type movement analysis, 2023 & 2030 (USD Million)
  • Fig. 25 Breast cancer market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Lung cancer market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Prostate cancer market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Colorectal cancer market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Brain tumor market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 AI in cancer diagnostics market, application outlook key takeaways (USD Million)
  • Fig. 32 AI in oncology market: Application movement analysis, 2023 & 2030 (USD Million)
  • Fig. 33 Diagnostics (pathology, cancer radiology) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Radiation therapy (Radiotherapy) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Chemotherapy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Immunotherapy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Research & development market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 AI in oncology market, end-use outlook key takeaways (USD Million)
  • Fig. 39 AI in oncology market: End-user movement analysis, 2023 & 2030 (USD Million)
  • Fig. 40 Hospitals market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Surgical centers and medical institutes market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Regional marketplace: Key takeaways
  • Fig. 44 AI in Oncology market: Regional outlook, 2023 & 2030 (USD Million)
  • Fig. 45 AI in Oncology market: Regional outlook, 2023 & 2030 (USD Million)
  • Fig. 46 North America AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Key country dynamics
  • Fig. 48 US AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 US AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Key country dynamics
  • Fig. 51 Canada AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Europe AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Key country dynamics
  • Fig. 54 UK AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Fig.54 Key country dynamics
  • Fig. 56 Germany AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Fig.56 Key country dynamics
  • Fig. 58 Spain AI In oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Key country dynamics
  • Fig. 60 France AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Key country dynamics
  • Fig. 62 Italy AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 Norway AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Key country dynamics
  • Fig. 66 Denmark AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Key country dynamics
  • Fig. 68 Sweden AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 Asia Pacific AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Key country dynamics
  • Fig. 71 Japan AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Key country dynamics
  • Fig. 73 China AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 India AI In oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 Key country dynamics
  • Fig. 77 Australia AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 78 Key country dynamics
  • Fig. 79 South Korea AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 80 Key country dynamics
  • Fig. 81 Thailand AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 82 Latin America AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 83 Key country dynamics
  • Fig. 84 Brazil AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 85 Key country dynamics
  • Fig. 86 Mexico AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million )
  • Fig. 87 Key country dynamics
  • Fig. 88 Argentina AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 89 MEA AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 90 Key country dynamics
  • Fig. 91 South Africa AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 92 Key country dynamics
  • Fig. 93 Saudi Arabia AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 94 Key country dynamics
  • Fig. 95 UAE AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 96 Key country dynamics
  • Fig. 97 Kuwait AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 98 Key company categorization
  • Fig. 99 Heat map analysis, 2022 - 2023